Assessment of Safety and Efficacy of SGLT2is Among LN Patients
NCT06113900
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Lupus Nephritis
Interventions
DRUG:
Dapagliflozin 10mg Tab orally once daily
Sponsor
Ain Shams University